Projects funded by the NCN

Inhibition of p21-Activated Kinase (PAK) as a new molecular target in the treatment of chronic myeloid leukemia (CML)

Call: OPUS 6 , Panel: NZ7

Principal investigator: dr hab. Sylwia Flis

Narodowy Instytut Leków

The influence of PERK-eIF2alpha pathway on the leukemia microenvironment; the role of cell-cell interactions and composi...

Call: SONATA BIS 3 , Panel: NZ3

Principal investigator: dr hab. Katarzyna Piwocka

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

The role of the PERK-eIF2alpha pathway in the survival and cancerogenic potential of Bcr-Abl expressing cells - in vivo ...

Call: PRELUDIUM 1 , Panel: NZ4

Principal investigator: dr Monika Kusio-Kobiałka

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

BCR-ABL-containing leukemic extracellular vesicles as a novel, immunosuppressive factor controlling function of regulato...

Call: PRELUDIUM 15 , Panel: NZ3

Principal investigator: Julian Swatler

Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

Linking stress response with genomic instability in chronic myeloid leukaemia cells; role of the PERK-eIF2α phosphorylat...

Call: OPUS 1 , Panel: NZ3

Principal investigator: dr hab. Katarzyna Piwocka

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Role of direct intercellular exchange of vesicles and proteins in modulating biological functions of CML cells by stroma...

Call: PRELUDIUM 13 , Panel: NZ3

Principal investigator: Marta Kolba

Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

Role of FMRP protein in the regulation of BRCA1 translation in leukemia cells.

Call: PRELUDIUM 12 , Panel: NZ3

Principal investigator: Magdalena Wołczyk

Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk